← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Holding	Trade Value	Theme Stocks	% of Portfolio	Status
1701	RPG Risk Paradigm Group Austin, Texas	$0	-$16.2K	0	–	Closed
1702	R.M. Davis Inc Portland, Maine	$0	-$212K	0	–	Closed
1703	RT Rockland Trust Hanover, Massachusetts	$0	-$211K	0	–	Closed
1704	SCM Schnieders Capital Management Pasadena, California	$0	-$237K	0	–	Closed
1705	SAM Senzar Asset Management New York	$0	-$10.3M	0	–	Closed
1706	SSA South Street Advisors New York	$0	-$210K	0	–	Closed
1707	SFPIA Stevens First Principles Investment Advisors Newport Beach, California	$0	-$3.49M	0	–	Closed
1708	SP SWS Partners Columbus, Ohio	$0	-$50K	0	–	Closed
1709	SCP Syntal Capital Partners Midland, Texas	$0	-$242K	0	–	Closed
1710	TH Timber Hill Greenwich, Connecticut	$0	-$712K	0	–	Closed
1711	TC Trilogy Capital Irvine, California	$0	$0	1	0%	Maintained
1712	VST Van Strum & Towne San Francisco, California	$0	-$206K	0	–	Closed
1713	VCM Virtue Capital Management Brentwood, Tennessee	$0	-$185K	0	–	Closed
1714	WAS WESPAC Advisors SoCal Pasadena, California	$0	-$176K	0	–	Closed
1715	WCM Whitener Capital Management Rocky Mount, North Carolina	$0	-$3K	0	–	Closed
1716	Wolverine Asset Management Chicago, Illinois	$0	-$191K	0	–	Closed
1717	WIS Wright Investors Service Shelton, Connecticut	$0	-$619K	0	–	Closed